AI assistant
Sending…
Bioventus Inc. — Director's Dealing 2021
Feb 12, 2021
32934_dirs_2021-02-11_eee6acf7-8181-4aa8-bc9b-9374a64fa0f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11
Reporting Person: HAWKINS WILLIAM A (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Profit Units | $ | Class A Common Stock (38288) | Direct |
Footnotes
F1: The Phantom Profit Units will become redeemable on the one-year anniversary of the consummation of the Issuer's initial public offering.
F2: Each Phantom Profit Unit represents a contingent right to receive shares of Class A common stock.
More from Bioventus Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17